CompletedNot Applicable

Effect of Expressive Arts Therapy on Death Anxiety in Intensive Care Unit Nurses

Turkey (Türkiye)66 participantsStarted 2024-03-01

Plain-language summary

This randomized controlled trial aimed to evaluate the effect of expressive arts therapy on death anxiety among intensive care unit nurses. A total of 66 nurses were randomly assigned to either an intervention group or a control group. The intervention group participated in a structured expressive arts therapy programme consisting of weekly sessions for six weeks, while the control group received no intervention during the study period. Death anxiety levels were assessed using the Death Anxiety Scale before and after the intervention. The study aimed to determine whether expressive arts therapy is effective in reducing death anxiety and improving psychological well-being among intensive care unit nurses.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Registered nurses working in intensive care units At least 1 year of experience in an intensive care setting Having previously encountered patient death in clinical practice Willingness to participate in the study Providing written informed Exclusion Criteria: Currently receiving psychological or psychiatric treatment for severe mental health problems Participation in similar psychological or psychosocial intervention programs during the study period

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in Death Anxiety Scale Total Score

Timeframe: Baseline and Week 6 (post-intervention)

Trial details

NCT IDNCT07462936

SponsorOndokuz Mayıs University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-07-01

View on ClinicalTrials.gov More Death Anxiety trials